Why the study?
Does N6-L-phenylisopropyladenosine inhibit catecholamine secretion in bovine adrenal medulla cells?
Does N6-L-phenylisopropyladenosine inhibit catecholamine secretion in bovine adrenal medulla cells?
The adenosine analogue PIA inhibits catecholamine secretion from bovine adrenal medulla cells by blocking voltage-sensitive calcium channels.
Provides mechanistic insight into adenosine actions on adrenal cells; leaves open relevance to human sympathetic regulation.
We reported earlier that adenine nucleotides and adenosine inhibit acetylcholine-induced catecholamine secretion from bovine adrenal medulla chromaffin cells. In this article, we used an adenosine analogue, N6-L-phenylisopropyladenosine (PIA), to study the mechanism underlying inhibition of catecholamine secretion by adenosine. PIA inhibits secretion induced by a nicotinic agonist, 1,1-dimethyl-4-phenylpiperazinium, or by elevated external K+. The half-maximal effect on 1,1-dimethyl-4-phenylpiperazinium-induced secretion occurred at approximately 5 x 10(-5) M. The inhibition is immediate and reversible. Fura-2 measurements of cytosolic free Ca2+ indicate that PIA inhibits Ca2+ elevation caused by stimulation; measurements of 45Ca2+ influx show that PIA inhibits uptake of Ca2+. PIA does not inhibit calcium-evoked secretion from digitonin-permeabilized cells, nor does PIA cause any significant change in the dependence of catecholamine secretion on calcium concentration. These data suggest that inhibition by PIA occurs at the level of the voltage-sensitive calcium channel.
No takes yet. Share an insight, caveat, or question.
Chern et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: